# Eli Lilly and Company (LLY) — Q4-2023 Earnings Results

**Report date:** 2024-02-06 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/LLY/earnings/Q4-2023

## Post-Earnings Brief

### Headline

Eli Lilly Beats on EPS, Stock Down N/A%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $2.49 | N/A | +1.18% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in the company's strategic direction. They emphasized their commitment to innovation and market expansion.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They noted ongoing investments in research and development to drive future growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Eli Lilly's earnings report shows a positive surprise in EPS, indicating better-than-expected profitability. However, the lack of revenue data and guidance leaves some uncertainty for investors. The stock reaction is not available, but the management's focus on future growth and innovation may influence investor sentiment moving forward.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/LLY/earnings/Q4-2023_